Notice: This company has been marked as potentially delisted and may not be actively trading. Genesis Healthcare (GEN) Stock Forecast & Price Target Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsCompetitorsDividendEarningsHeadlinesInsider TradesOptions ChainOwnershipTrends GEN Analyst Ratings Over TimeTypeCurrent Forecast11/15/23 to 11/14/241 Month Ago10/16/23 to 10/15/243 Months Ago8/17/23 to 8/16/241 Year Ago11/15/22 to 11/15/23Strong Buy0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)Buy3 Buy rating(s)2 Buy rating(s)2 Buy rating(s)2 Buy rating(s)Hold3 Hold rating(s)3 Hold rating(s)3 Hold rating(s)1 Hold rating(s)Sell0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)Consensus Price Target$29.33$27.40$27.20$24.00Forecasted Upside-3.86% Downside-2.53% Downside7.64% Upside21.46% UpsideConsensus RatingModerate BuyHoldHoldModerate Buy DeFi Coin on Verge of Breakout! (Ad)The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Claim your FREE book now before it's too late! GEN Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History GEN Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table Genesis Healthcare Stock vs. The CompetitionTypeGenesis HealthcareBusiness Services CompaniesS&P 500Consensus Rating Score 2.50 2.68 2.50Consensus RatingModerate BuyModerate BuyModerate BuyPredicted Upside-3.86% Downside336.74% Upside8.16% UpsideNews Sentiment RatingNeutral NewsSee Recent GEN NewsPositive NewsPositive News Recent Analyst Forecasts and Stock Ratings All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Years 5 Years Time Frame Start Date End Date Most Recent from Each Brokerage All Show Export to Excel DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails10/31/2024Wells Fargo & Company3 of 5 stars Boost TargetOverweight ➝ Overweight$35.00 ➝ $37.00+27.10%10/31/2024Barclays3 of 5 stars Boost TargetEqual Weight ➝ Equal Weight$28.00 ➝ $30.00+11.48%8/2/2024Royal Bank of Canada4 of 5 stars Boost TargetSector Perform ➝ Sector Perform$25.00 ➝ $28.00+11.29%6/7/2024Morgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy rating DowngradeOverweight ➝ Equal Weight$28.00 ➝ $27.00+6.13%5/28/2024ArgusSubscribe to MarketBeat All Access for the recommendation accuracy rating Boost TargetBuy ➝ Buy$26.00 ➝ $29.00+16.51%11/16/2023Bank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy rating Initiated CoverageBuy$25.00+26.52%5/19/2023Evercore ISISubscribe to MarketBeat All Access for the recommendation accuracy rating Initiated CoverageOutperform$27.00+67.49%Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 12:42 PM ET. GEN Forecast - Frequently Asked Questions What is Genesis Healthcare's forecast for 2025? According to the research reports of 6 Wall Street equities research analysts, the average twelve-month stock price forecast for Genesis Healthcare is $29.33, with a high forecast of $37.00 and a low forecast of $25.00. Should I buy or sell Genesis Healthcare stock right now? 6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Genesis Healthcare in the last twelve months. There are currently 3 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" GEN shares. Does Genesis Healthcare's stock price have much downside? According to analysts, Genesis Healthcare's stock has a predicted downside of -3.86% based on their 12-month stock forecasts. What analysts cover Genesis Healthcare? Genesis Healthcare has been rated by research analysts at Barclays, and Wells Fargo & Company in the past 90 days. Do Wall Street analysts like Genesis Healthcare more than its competitors? Analysts like Genesis Healthcare less than other "business services" companies. The consensus rating score for Genesis Healthcare is 2.50 while the average consensus rating score for "business services" companies is 2.68. Learn more on how GEN compares to other companies. Stock Forecasts and Research Tools Related Companies ADSK Stock Forecast TEAM Stock Forecast MSTR Stock Forecast NTES Stock Forecast SQ Stock Forecast DDOG Stock Forecast EA Stock Forecast SNOW Stock Forecast VEEV Stock Forecast HUBS Stock Forecast Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top Rated Stocks Top Rated Stocks Top Rated Dividend Stocks Top Rated Small-Cap Stocks Top Rated Tech Stocks Most Upgraded Stocks Most Downgraded Stocks Lowest Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter DeFi Coin on Verge of Breakout! (Ad)The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Claim your FREE book now before it's too late! This page (NYSE:GEN) was last updated on 11/14/2024 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | SponsoredTrump’s Back, but DC’s Coming for Your Money!Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredWatch this before it gets removed If you missed it, my emergency election broadcast is now available - but will be removed soonPorter & Company | SponsoredNew post-election stock warning from Wall StreetIf you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding Genesis Healthcare, Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share Genesis Healthcare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
